Onsior 20 mg Tablet is a Health Canada–registered veterinary drug (DIN 02374714) held by Elanco Canada Limited, containing Robenacoxib. Health Canada lists its status as Marketed (status date 30 Jun 2017). Nexara Health has matched 63 registrations of Robenacoxib across 7 other regulated markets, 7 of them in the same strength and dosage form.

Health Canada registration

Robenacoxib registered in other markets

63 registrations of the same molecule in 7 national registries outside Canada (first 38 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.

See every manufacturer of Robenacoxib worldwide →

Regulator price references for Robenacoxib

Published list or reimbursement prices for Robenacoxib presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.

Marketed Canadian products with the same active ingredient

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Onsior (DIN 02374714) marketed in Canada?

Yes. Health Canada lists DIN 02374714 as Marketed as of 30 Jun 2017.

Who holds the Canadian licence for this product?

Elanco Canada Limited is the company of record in the Health Canada Drug Product Database.

Is Robenacoxib registered outside Canada?

Yes — Nexara Health has matched 63 registrations in 7 other markets, including 7 in the same strength and dosage form (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02374714, status date 2017-06-30; national medicine registries: EMA centrally authorised, FDA NDC, Fimea Perusrekisteri, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, NPRA, URPL RPL; price sources: Lyfjastofnun lyfjaverdskra. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02374714, status date 2017-06-30; national medicine registries: EMA centrally authorised, FDA NDC, Fimea Perusrekisteri, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, NPRA, URPL RPL; price sources: Lyfjastofnun lyfjaverdskra.

Health Canada Drug Product Database (DPD), DIN 02374714, status date 2017-06-30; national medicine registries: EMA centrally authorised, FDA NDC, Fimea Perusrekisteri, Laegemiddelstyrelsen, Lyfjastofnun lyfjaverdskra, NPRA, URPL RPL; price sources: Lyfjastofnun lyfjaverdskra. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.